Non-nucleoside reverse transcriptase inhibitors
US7208509B2 · kind B2 · utility
12Cited by
8References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2004 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | Aug 5, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D285/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to novel heterocyclic compounds of formula I wherein R1—R4, X1 and X2 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I, pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula I. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.